Inmet S.A. is a pioneer biotechnological company from Argentina that develops genetically optimized microorganisms for the production of high-value compounds from low-cost feedstocks at the lowest environmental impact.

Inmet has implemented technological solutions that replace chemical products by biological ones, both sustainable and biodegradable.

Inmet started in 2011, as an initiative of researchers from IBR-CONICET, Diego de Mendoza and Gustavo Schujman, and INDEAR. Dr. Diego de Mendoza is Career Investigator from the National Research Council of Argentina (CONICET) and Professor Emeritus at the University of Rosario. He was co-founder and Director of the Institute of Molecular and Cellular Biology from Rosario (IBR). He was an International Scholar of the Howard Hughes Medical Institute (HHMI) and awarded the Guggenheim fellowship, the Humboldt Award from Alexander von Humboldt Foundation and the prize Investigator of the Argentine Nation granted by the President of Argentina. The research program carried out in the laboratory of Dr. de Mendoza centers on lipid metabolism in model organisms. In his laboratory were elucidated major signaling pathways controlling the overall rate and quality of fatty acid biosynthesis in the bacterium Bacilus subtilis, which are important to use this microorganism as a bio-factory of lipid-derived molecules. The laboratory also studies sterol metabolism in nematodes and its potential application in human health and agriculture.

Inmet promotes integration and collaborative work with private companies, universities, research institutes and the National government, to achieve economic development based on the knowledge derived from science and technology.

We provide state-of-art R&D Services in the field of bacterial Metabolic Engineering with the support of ultimate generation equipment and professional staff that contributes to an excellent technological advice to public and private institutions.